{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:20:41Z","timestamp":1771006841704,"version":"3.50.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1097\/jcp.0000000000000385","type":"journal-article","created":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T20:03:41Z","timestamp":1439323421000},"page":"591-595","source":"Crossref","is-referenced-by-count":23,"title":["Effectiveness and Predictors of Continuation of Paliperidone Palmitate Long-Acting Injection Treatment"],"prefix":"10.1097","volume":"35","author":[{"given":"Richard","family":"Whale","sequence":"first","affiliation":[]},{"given":"Marco","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Sharon","family":"Cuthbert","sequence":"additional","affiliation":[]},{"given":"Renata","family":"Fialho","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-16-20210128","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1192\/bjp.179.4.290","article-title":"Systematic meta-review of depot antipsychotic drugs for people with schizophrenia.","volume":"179","author":"Adams","year":"2001","journal-title":"Br J Psychiatry"},{"key":"R2-16-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.schres.2009.10.026","article-title":"Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: a randomized, double-blind, placebo-controlled study.","volume":"116","author":"Hough","year":"2010","journal-title":"Schizophr Res"},{"key":"R3-16-20210128","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.schres.2010.11.020","article-title":"Oral versus depot antipsychotic drugs for schizophreniaa critical systematic review and meta-analysis of randomised long-term trials.","volume":"127","author":"Leucht","year":"2011","journal-title":"Schizophr Res"},{"key":"R4-16-20210128","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/schbul\/sbs150","article-title":"Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials.","volume":"40","author":"Kishimoto","year":"2014","journal-title":"Schizophr Bull"},{"key":"R5-16-20210128","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4088\/JCP.13r08440","article-title":"Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies.","volume":"74","author":"Kishimoto","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"R6-16-20210128","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1176\/appi.ajp.2011.10081224","article-title":"A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.","volume":"168","author":"Tiihonen","year":"2011","journal-title":"Am J Psychiatry"},{"key":"R7-16-20210128","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1176\/ps.2008.59.3.315","article-title":"Time to discontinuation of depot and oral first-generation antipsychotics in the usual care of schizophrenia.","volume":"59","author":"Zhu","year":"2008","journal-title":"Psychiatr Serv"},{"key":"R8-16-20210128","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"R10-16-20210128","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"key":"R11-16-20210128","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/acps.12201","article-title":"Paliperidone palmitate long-acting injectionprospective year-long follow-up of use in clinical practice.","volume":"130","author":"Attard","year":"2014","journal-title":"Acta Psychiatr Scand"},{"key":"R12-16-20210128","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1017\/S1461145705006309","article-title":"Prospective 6-month follow-up of patients prescribed risperidone long-acting injection: factors predicting favourable outcome.","volume":"9","author":"Taylor","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"key":"R14-16-20210128","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.schres.2011.04.030","article-title":"Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.","volume":"130","author":"Baloush-Kleinman","year":"2011","journal-title":"Schizophr Res"},{"key":"R15-16-20210128","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/JCP.0b013e3181dd3103","article-title":"A randomized, placebo-controlled study to assess the efficacy and safety of 3 doses of paliperidone palmitate in adults with acutely exacerbated schizophrenia.","volume":"30","author":"Pandina","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"R16-16-20210128","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/schbul\/sbl011","article-title":"Medication adherence in schizophrenia: exploring patients, carers and professionals views.","volume":"32","author":"Kikkert","year":"2006","journal-title":"Schizophr Bull"},{"key":"R17-16-20210128","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jamapsychiatry.2013.19","article-title":"Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reductiondiscontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.","volume":"70","author":"Wunderink","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"R19-16-20210128","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2147\/PPA.S15337","article-title":"Opinions of French patients with schizophrenia regarding injectable medication.","volume":"5","author":"Caroli","year":"2011","journal-title":"Patient Prefer Adherence"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0000000000000385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:49:02Z","timestamp":1620956942000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201510000-00016"}},"subtitle":["A 12-Month Naturalistic Cohort Study"],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0000000000000385","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}